Maridebart Cafraglutide

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Maridebart Cafraglutide
Treatment and conditionWhere it standsTrials
Maridebart Cafraglutide for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Maridebart Cafraglutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Maridebart Cafraglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Maridebart Cafraglutide for overweightPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1